• Join
  • Login
  • Contact

Search abstracts

Formulary and logistical considerations with the introduction of cell-based gene therapies

  • In: Cell-based gene therapy - Promise and challenges on Wednesday, 25 September 2019, 9:00-12:00
  • At: AbuDhabi (United Arab Emirates) (2019)
  • Type: Presentation
  • By: KIRSA, Suzanne (Monash Health, Australia)
  • Abstract:

    Gene Therapies are being commercialised across the world. These treatments are not conventional therapeutic products. Regulatory approvals differ across countries. Hospitals may choose approval and governance processes that by-pass the Pharmacy or Therapeutics committees unless Pharmacists actively pursue involvement. Toxicity profiles will


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses